Palisade Bio Capital Expenditures (CapEx) Growth & History (PALI)

Palisade Bio's capital expenditures (capex) was $0 for fiscal 2024.

View full Palisade Bio company overview

Palisade Bio annual capital expenditures (capex) history

Palisade Bio annual capital expenditures (capex)

Fiscal yearPeriod endedCapital expenditures (CapEx)ChangeGrowth
20242024-12-31$0−$4,000
20232023-12-31$4,000−$6,000−60.00%
20222022-12-31$10,000$10,000
20212021-12-31$0−$6,000
20202020-12-31$6,000
20182018-12-31$1,714−$9,687−84.97%
20172017-12-31$11,401−$86,687−88.38%
20162016-12-31$98,088−$78,184−44.35%
20152015-12-31$176,272−$31,621−15.21%
20142014-12-31$207,893$82,531+65.83%
20132013-12-31$125,362$86,142+219.64%
20122012-12-31$39,220−$157,192−80.03%
20112011-12-31$196,412$120,090+157.35%
20102010-12-31$76,322−$12,056−13.64%
20092009-12-31$88,378

Palisade Bio capital expenditures (capex) trends

Between the periods ended 2009-12-31 and 2024-12-31, Palisade Bio's capital expenditures (capex) decreased from $88,378 to $0, a change of −$88,378. The latest reported quarter, Q3 2024, shows $0.

About the metric

What capital expenditures (CapEx) mean

Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.

Calculation and source

SEC-reported capital expenditures

TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Palisade Bio source filings ↗

Community posts

It’s quiet here.

No posts about PALI yet. Start the conversation.

Write the first post